ATLANTA, Jan. 6 /PRNewswire/ -- CorMatrix Cardiovascular, Inc., an Atlanta-based company dedicated to developing and delivering unique extracellular matrix (ECM(TM)) biomaterial devices that harness the body's innate ability to repair damaged cardiovascular tissue, today announced that they will be hosting a symposium on "Rethinking the Future of Cardiac Care" for invited surgeons during the Society of Thoracic Surgeons' (STS) 46th Annual Meeting.
The symposium will take place on Monday, January 25th from 6:30-9:30 p.m. EST at the Museum of Discovery and Science in Fort Lauderdale and will include an address by CorMatrix Board Member and former Florida Governor Jeb Bush, who will speak on future considerations for the American healthcare system, joined by leading stem cell researcher Doris Taylor, Ph.D., Director of the University of Minnesota's Center for Cardiac Repair, who will speak on "Whole Organ Matrix: A Superior Scaffold."
Governor Bush has been a member of the CorMatrix Board since January 2009 and has just begun his second term as a director. "Having been involved with CorMatrix for the past year, I have an appreciation for the great work that they are doing," commented Governor Bush. "The cost of cardiac care and our ability to care for those with cardiovascular disease is a critical problem in today's healthcare system. New advancements in technology will help address the growing economic burdens of this disease and I am pleased to be working with a company that is innovating and looking to make a meaningful improvement in outcomes for patients with cardiac disease."
During his tenure as Florida Governor, Governor Bush championed a number of programs on the state and national level including the bolstering of Florida's life sciences industry and Medicaid Reform. Currently, Governor Bush is the President of the consulting firm Jeb Bush and Associates and serves on a number of industry, charitable and civic boards.
"CorMatrix is committed to leading the way toward significant advancements for cardiac surgeons and their patients," said Beecher Lewis, President and Chief Operating Officer of CorMatrix Cardiovascular. "With growing interest and continued adoption from the clinical community, we believe that we have a platform technology that can offer meaningful improvements in cardiac care for patients."
About CorMatrix Cardiovascular, Inc.
CorMatrix Cardiovascular, a privately held company based in Atlanta, Georgia, is dedicated to developing and delivering innovative cardiovascular devices that harness the body's own innate ability to remodel damaged tissue. For more information, visit www.cormatrix.com.
SOURCE CorMatrix Cardiovascular, Inc.